March 24, 2017 5:00pm

 

The DOW and NYSE fell while the NASDAQ outperformed

 

… The major indexes were on track for weekly losses.

… The iShares NASDAQ Biotechnology (IBB) closed UP +0.37%.

… The VIX, “fear gauge” closed near 13.3 after Thursday’s 12.4

… Pre-open indications:  5 hits and 1 miss

 

I answer one question, in which company should investors put, keep and commit their money

 

 

RMi’s daily and continual “reads” of the goings-on of the SCG&RT sector can improve investor’s and trader’s odds - just because a stock underperforms the market doesn’t mean you have to lose money.

 

 

Henry’omics:

From the pre-open’s investor’s letter title,” We are suffering from Stockholm syndrome, a condition that causes investors to develop a psychological alliance with their portfolios as a survival strategy during share pricing delusions.

  • Reiterating, “Once an investor gets burned; it eliminates any thought of coming back as the BAD taste lasts a LONG time and everybody talks!”

Friday always scares me – for those equities to be TOO long over a weekend in this political environment.

  • The days of sideway and alternating closes will continue as the month and quarter end.

Measures of risk are rearing their heads back up, with the CBOE Volatility Index VIX, +7.39% closing at its highest level of the year in Thursday trade and threatening to close above its 200-day moving average, now at 13.54, for the first time since December of last year.

  • Whatever the case, volatility might be here to stay, which for some investors could be a good thing …

I also DON’T feel well about April … after all the bad karma – the sector could be worse off than the past few months!

 

I wasn’t elected sheriff of our universe yet I am a preacher of best and better practices as I have BEEN - there from the corporate and investment side; but I HATE what some of this reporting considered investor communication has become - MISLEADING!

 

 

What analytics were there today and why it was important in today’s sector outcomes?

… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded near 13.3 after Thursday’s 12.4 after Wednesday’s 12.2 after Tuesday’s  12.5 – UP +10%; following Monday’s 11.35 after Friday’s 11 following last Thursday’s post 11.3;

…The NASDAQ closed UP +11.05 or +0.19% to 5828.74 and the DOW closed DOWN -59.86 or -0.29% to 20,596.72;

…The iShares Russell 2000 (IWM) indicated a negative -0.16% at the pre-open and closed UP +0.07%;

… The iShares NASDAQ Biotechnology (IBB) and indicated a positive +0.02% at the pre-open and closed UP +0.37%.

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The opening bell was positive with an A/DL of 23/18 and 2 flats;

·         The mid-day was positive with an A/DL of 26/16 and 1 flat;

·         The close was positive with an A/DL of 27/13 and 3 flats;

 

 

Pre-open indications:  5 hit and 1 miss …

  • Applied Genetic Technologies (AGTC) closed up +$0.05 – hit;
  • Bellicum Pharmaceuticals (BLCM) closed down -$0.86 – hit;
  • bluebird bio (BLUE) closed UP +$1.15 – hit;
  • Caladrius Biosciences (CLBS) closed down -$0.07 – miss;
  • Cytori (CYTX) closed up +$0.001 – hit;
  • Kite Pharma (KITE) closed up +$2.34 – hit;

 

 

… Decliners ranged from -0.39% <JUNO> to -6.67% <BLCM> in 13 equities;

… Gainers ranged from +0.13% <CLLS> to +9.93% <VSTM> in 27 equities;

 

 

The upside …

  • Kite Pharma (KITE) closed up +$2.34 after Thursday’s-$1.88 after Wednesday’s $0.29 following Tuesday’s -$8.27 following Monday’s +$0.96 after last Friday’s -$0.37;
  • bluebird bio (BLUE) closed UP +$1.15 after Thursday’s +$0.65 after Wednesday’s +$2.25 after Tuesday’s  -$7.45 after Monday’s -$0.90 after last Friday’s -$0.35;
  • Spark Therapeutics (ONCE) closed UP +$0.56 after Thursday’s down -$0.41;
  • Intrexon (XON) closed UP +$0.21;
  • MiMedx (MDXG) closed UP +$0.18;

 

The downside:

  • Bellicum Pharmaceuticals (BLCM) closed down another -$0.86 after Thursday’s -$1.47 after last Wednesday’s +$0.46;
  • Aduro Biotech (ADRO) closed down -$0.20;
  • Mesoblast (MESO) closed down -$0.19 after Thursday’s +$0.56 after Wednesday’s -$0.56 following Tuesday’s +$0.55 after Monday’s +$0. 58;
  • Cesca Therapeutics (KOOL) closed down -$0.12;
  • VistaGen (VTGN) closed down -$0.13

 

Flat:

  • Asterias Biotherapeutics (NYSEMKT: AST) at $3.25;
  • AxoGen (AXGN) at $10.05;
  • ReNeuron (RENE.L) at $2.35;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.